Global and United States Transmucosal Drug Delivery Market Report & Forecast 2022-2028

Global and United States Transmucosal Drug Delivery Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Transmucosal Drug Delivery Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million) Introduction
1.2 Global Transmucosal Drug Delivery Outlook 2017 VS 2022 VS 2028
1.2.1 Global Transmucosal Drug Delivery Market Size for the Year 2017-2028
1.2.2 Global Transmucosal Drug Delivery Market Size for the Year 2017-2028
1.3 Transmucosal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Transmucosal Drug Delivery in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Transmucosal Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Transmucosal Drug Delivery Market Dynamics
1.4.1 Transmucosal Drug Delivery Industry Trends
1.4.2 Transmucosal Drug Delivery Market Drivers
1.4.3 Transmucosal Drug Delivery Market Challenges
1.4.4 Transmucosal Drug Delivery Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Transmucosal Drug Delivery by Type
2.1 Transmucosal Drug Delivery Market Segment by Type
2.1.1 Passive Transdermal Drug Delivery
2.1.2 Active Transdermal Drug Delivery
2.2 Global Transmucosal Drug Delivery Market Size by Type (2017, 2022 & 2028)
2.3 Global Transmucosal Drug Delivery Market Size by Type (2017-2028)
2.4 United States Transmucosal Drug Delivery Market Size by Type (2017, 2022 & 2028)
2.5 United States Transmucosal Drug Delivery Market Size by Type (2017-2028)
3 Transmucosal Drug Delivery by Application
3.1 Transmucosal Drug Delivery Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Transmucosal Drug Delivery Market Size by Application (2017, 2022 & 2028)
3.3 Global Transmucosal Drug Delivery Market Size by Application (2017-2028)
3.4 United States Transmucosal Drug Delivery Market Size by Application (2017, 2022 & 2028)
3.5 United States Transmucosal Drug Delivery Market Size by Application (2017-2028)
4 Global Transmucosal Drug Delivery Competitor Landscape by Company
4.1 Global Transmucosal Drug Delivery Market Size by Company
4.1.1 Top Global Transmucosal Drug Delivery Companies Ranked by Revenue (2021)
4.1.2 Global Transmucosal Drug Delivery Revenue by Player (2017-2022)
4.2 Global Transmucosal Drug Delivery Concentration Ratio (CR)
4.2.1 Transmucosal Drug Delivery Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Transmucosal Drug Delivery in 2021
4.2.3 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Transmucosal Drug Delivery Headquarters, Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million) Type
4.3.1 Global Transmucosal Drug Delivery Headquarters and Area Served
4.3.2 Global Transmucosal Drug Delivery Companies Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Transmucosal Drug Delivery Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Transmucosal Drug Delivery Market Size by Company
4.5.1 Top Transmucosal Drug Delivery Players in United States, Ranked by Revenue (2021)
4.5.2 United States Transmucosal Drug Delivery Revenue by Players (2020, 2021 & 2022)
5 Global Transmucosal Drug Delivery Market Size by Region
5.1 Global Transmucosal Drug Delivery Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Transmucosal Drug Delivery Market Size by Region (2017-2028)
5.2.1 Global Transmucosal Drug Delivery Market Size by Region: 2017-2022
5.2.2 Global Transmucosal Drug Delivery Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.1.2 North America Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Transmucosal Drug Delivery Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.3.2 Europe Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.4.2 Latin America Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Transmucosal Drug Delivery Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Transmucosal Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 3M Pharmaceuticals
7.1.1 3M Pharmaceuticals Company Details
7.1.2 3M Pharmaceuticals Business Overview
7.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Introduction
7.1.4 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.1.5 3M Pharmaceuticals Recent Development
7.2 Acrux Limited
7.2.1 Acrux Limited Company Details
7.2.2 Acrux Limited Business Overview
7.2.3 Acrux Limited Transmucosal Drug Delivery Introduction
7.2.4 Acrux Limited Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.2.5 Acrux Limited Recent Development
7.3 ALZA Corporation
7.3.1 ALZA Corporation Company Details
7.3.2 ALZA Corporation Business Overview
7.3.3 ALZA Corporation Transmucosal Drug Delivery Introduction
7.3.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.3.5 ALZA Corporation Recent Development
7.4 Antares Pharma, Inc.
7.4.1 Antares Pharma, Inc. Company Details
7.4.2 Antares Pharma, Inc. Business Overview
7.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Introduction
7.4.4 Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.4.5 Antares Pharma, Inc. Recent Development
7.5 Apricus BioSciences, Inc
7.5.1 Apricus BioSciences, Inc Company Details
7.5.2 Apricus BioSciences, Inc Business Overview
7.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Introduction
7.5.4 Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.5.5 Apricus BioSciences, Inc Recent Development
7.6 Aveva Drug Delivery Systems
7.6.1 Aveva Drug Delivery Systems Company Details
7.6.2 Aveva Drug Delivery Systems Business Overview
7.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Introduction
7.6.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.6.5 Aveva Drug Delivery Systems Recent Development
7.7 Corium International, Inc
7.7.1 Corium International, Inc Company Details
7.7.2 Corium International, Inc Business Overview
7.7.3 Corium International, Inc Transmucosal Drug Delivery Introduction
7.7.4 Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.7.5 Corium International, Inc Recent Development
7.8 DURECT Corporation
7.8.1 DURECT Corporation Company Details
7.8.2 DURECT Corporation Business Overview
7.8.3 DURECT Corporation Transmucosal Drug Delivery Introduction
7.8.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.8.5 DURECT Corporation Recent Development
7.9 Generex Biotechnology Corporation
7.9.1 Generex Biotechnology Corporation Company Details
7.9.2 Generex Biotechnology Corporation Business Overview
7.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Introduction
7.9.4 Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.9.5 Generex Biotechnology Corporation Recent Development
7.10 Inovio Pharmaceuticals, Inc.
7.10.1 Inovio Pharmaceuticals, Inc. Company Details
7.10.2 Inovio Pharmaceuticals, Inc. Business Overview
7.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
7.10.4 Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.10.5 Inovio Pharmaceuticals, Inc. Recent Development
7.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
7.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
7.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
7.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Introduction
7.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
7.12 MedPharm LTD
7.12.1 MedPharm LTD Company Details
7.12.2 MedPharm LTD Business Overview
7.12.3 MedPharm LTD Transmucosal Drug Delivery Introduction
7.12.4 MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.12.5 MedPharm LTD Recent Development
7.13 Mylan, Inc.
7.13.1 Mylan, Inc. Company Details
7.13.2 Mylan, Inc. Business Overview
7.13.3 Mylan, Inc. Transmucosal Drug Delivery Introduction
7.13.4 Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.13.5 Mylan, Inc. Recent Development
7.14 Nemaura Pharma Ltd
7.14.1 Nemaura Pharma Ltd Company Details
7.14.2 Nemaura Pharma Ltd Business Overview
7.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Introduction
7.14.4 Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.14.5 Nemaura Pharma Ltd Recent Development
7.15 Nitto Denko Corporation
7.15.1 Nitto Denko Corporation Company Details
7.15.2 Nitto Denko Corporation Business Overview
7.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Introduction
7.15.4 Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.15.5 Nitto Denko Corporation Recent Development
7.16 Noven Pharmaceuticals, Inc.
7.16.1 Noven Pharmaceuticals, Inc. Company Details
7.16.2 Noven Pharmaceuticals, Inc. Business Overview
7.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
7.16.4 Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.16.5 Noven Pharmaceuticals, Inc. Recent Development
7.17 Pantec Biosolutions AG
7.17.1 Pantec Biosolutions AG Company Details
7.17.2 Pantec Biosolutions AG Business Overview
7.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Introduction
7.17.4 Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.17.5 Pantec Biosolutions AG Recent Development
7.18 Tapemark
7.18.1 Tapemark Company Details
7.18.2 Tapemark Business Overview
7.18.3 Tapemark Transmucosal Drug Delivery Introduction
7.18.4 Tapemark Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.18.5 Tapemark Recent Development
7.19 tesa Labtec GmbH
7.19.1 tesa Labtec GmbH Company Details
7.19.2 tesa Labtec GmbH Business Overview
7.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Introduction
7.19.4 tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.19.5 tesa Labtec GmbH Recent Development
7.20 TEVA Pharmaceutical Industries Ltd.
7.20.1 TEVA Pharmaceutical Industries Ltd. Company Details
7.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
7.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Introduction
7.20.4 TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.20.5 TEVA Pharmaceutical Industries Ltd. Recent Development
7.21 Zosano Pharma
7.21.1 Zosano Pharma Company Details
7.21.2 Zosano Pharma Business Overview
7.21.3 Zosano Pharma Transmucosal Drug Delivery Introduction
7.21.4 Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2017-2022)
7.21.5 Zosano Pharma Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Transmucosal Drug Delivery Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Transmucosal Drug Delivery Market Trends
Table 3. Transmucosal Drug Delivery Market Drivers
Table 4. Transmucosal Drug Delivery Market Challenges
Table 5. Transmucosal Drug Delivery Market Restraints
Table 6. Global Transmucosal Drug Delivery Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Transmucosal Drug Delivery Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Transmucosal Drug Delivery Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Transmucosal Drug Delivery Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Transmucosal Drug Delivery Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Transmucosal Drug Delivery Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Transmucosal Drug Delivery Revenue Share by Player, 2017-2022
Table 13. Global Transmucosal Drug Delivery Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Transmucosal Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transmucosal Drug Delivery as of 2021)
Table 15. Top Players of Transmucosal Drug Delivery in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Transmucosal Drug Delivery Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Transmucosal Drug Delivery Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Transmucosal Drug Delivery Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Transmucosal Drug Delivery Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Transmucosal Drug Delivery Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Transmucosal Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Transmucosal Drug Delivery Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Transmucosal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Transmucosal Drug Delivery Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Transmucosal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Transmucosal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Transmucosal Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. 3M Pharmaceuticals Company Details
Table 31. 3M Pharmaceuticals Business Overview
Table 32. 3M Pharmaceuticals Transmucosal Drug Delivery Product
Table 33. 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 34. 3M Pharmaceuticals Recent Development
Table 35. Acrux Limited Company Details
Table 36. Acrux Limited Business Overview
Table 37. Acrux Limited Transmucosal Drug Delivery Product
Table 38. Acrux Limited Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 39. Acrux Limited Recent Development
Table 40. ALZA Corporation Company Details
Table 41. ALZA Corporation Business Overview
Table 42. ALZA Corporation Transmucosal Drug Delivery Product
Table 43. ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 44. ALZA Corporation Recent Development
Table 45. Antares Pharma, Inc. Company Details
Table 46. Antares Pharma, Inc. Business Overview
Table 47. Antares Pharma, Inc. Transmucosal Drug Delivery Product
Table 48. Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 49. Antares Pharma, Inc. Recent Development
Table 50. Apricus BioSciences, Inc Company Details
Table 51. Apricus BioSciences, Inc Business Overview
Table 52. Apricus BioSciences, Inc Transmucosal Drug Delivery Product
Table 53. Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 54. Apricus BioSciences, Inc Recent Development
Table 55. Aveva Drug Delivery Systems Company Details
Table 56. Aveva Drug Delivery Systems Business Overview
Table 57. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product
Table 58. Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 59. Aveva Drug Delivery Systems Recent Development
Table 60. Corium International, Inc Company Details
Table 61. Corium International, Inc Business Overview
Table 62. Corium International, Inc Transmucosal Drug Delivery Product
Table 63. Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 64. Corium International, Inc Recent Development
Table 65. DURECT Corporation Company Details
Table 66. DURECT Corporation Business Overview
Table 67. DURECT Corporation Transmucosal Drug Delivery Product
Table 68. DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 69. DURECT Corporation Recent Development
Table 70. Generex Biotechnology Corporation Company Details
Table 71. Generex Biotechnology Corporation Business Overview
Table 72. Generex Biotechnology Corporation Transmucosal Drug Delivery Product
Table 73. Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 74. Generex Biotechnology Corporation Recent Development
Table 75. Inovio Pharmaceuticals, Inc. Company Details
Table 76. Inovio Pharmaceuticals, Inc. Business Overview
Table 77. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product
Table 78. Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 79. Inovio Pharmaceuticals, Inc. Recent Development
Table 80. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
Table 81. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
Table 82. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product
Table 83. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 84. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
Table 85. MedPharm LTD Company Details
Table 86. MedPharm LTD Business Overview
Table 87. MedPharm LTD Transmucosal Drug Delivery Product
Table 88. MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 89. MedPharm LTD Recent Development
Table 90. Mylan, Inc. Company Details
Table 91. Mylan, Inc. Business Overview
Table 92. Mylan, Inc. Transmucosal Drug Delivery Product
Table 93. Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 94. Mylan, Inc. Recent Development
Table 95. Nemaura Pharma Ltd Company Details
Table 96. Nemaura Pharma Ltd Business Overview
Table 97. Nemaura Pharma Ltd Transmucosal Drug Delivery Product
Table 98. Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 99. Nemaura Pharma Ltd Recent Development
Table 100. Nitto Denko Corporation Company Details
Table 101. Nitto Denko Corporation Business Overview
Table 102. Nitto Denko Corporation Transmucosal Drug Delivery Product
Table 103. Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 104. Nitto Denko Corporation Recent Development
Table 105. Noven Pharmaceuticals, Inc. Company Details
Table 106. Noven Pharmaceuticals, Inc. Business Overview
Table 107. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product
Table 108. Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 109. Noven Pharmaceuticals, Inc. Recent Development
Table 110. Pantec Biosolutions AG Company Details
Table 111. Pantec Biosolutions AG Business Overview
Table 112. Pantec Biosolutions AG Transmucosal Drug Delivery Product
Table 113. Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 114. Pantec Biosolutions AG Recent Development
Table 115. Tapemark Company Details
Table 116. Tapemark Business Overview
Table 117. Tapemark Transmucosal Drug Delivery Product
Table 118. Tapemark Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 119. Tapemark Recent Development
Table 120. tesa Labtec GmbH Company Details
Table 121. tesa Labtec GmbH Business Overview
Table 122. tesa Labtec GmbH Transmucosal Drug Delivery Product
Table 123. tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 124. tesa Labtec GmbH Recent Development
Table 125. TEVA Pharmaceutical Industries Ltd. Company Details
Table 126. TEVA Pharmaceutical Industries Ltd. Business Overview
Table 127. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product
Table 128. TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 129. TEVA Pharmaceutical Industries Ltd. Recent Development
Table 130. Zosano Pharma Company Details
Table 131. Zosano Pharma Business Overview
Table 132. Zosano Pharma Transmucosal Drug Delivery Product
Table 133. Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2017-2022) & (US$ Million)
Table 134. Zosano Pharma Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Transmucosal Drug Delivery Product Picture
Figure 2. Global Transmucosal Drug Delivery Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Transmucosal Drug Delivery Market Size 2017-2028 (US$ Million)
Figure 4. United States Transmucosal Drug Delivery Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Transmucosal Drug Delivery Market Size 2017-2028 (US$ Million)
Figure 6. United States Transmucosal Drug Delivery Market Share in Global 2017-2028
Figure 7. Transmucosal Drug Delivery Report Years Considered
Figure 8. Product Picture of Passive Transdermal Drug Delivery
Figure 9. Product Picture of Active Transdermal Drug Delivery
Figure 10. Global Transmucosal Drug Delivery Market Share by Type in 2022 & 2028
Figure 11. Global Transmucosal Drug Delivery Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Transmucosal Drug Delivery Market Share by Type (2017-2028)
Figure 13. United States Transmucosal Drug Delivery Market Share by Type in 2022 & 2028
Figure 14. United States Transmucosal Drug Delivery Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Transmucosal Drug Delivery Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Clinic
Figure 18. Product Picture of Others
Figure 19. Global Transmucosal Drug Delivery Market Share by Application in 2022 & 2028
Figure 20. Global Transmucosal Drug Delivery Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Transmucosal Drug Delivery Market Share by Application (2017-2028)
Figure 22. United States Transmucosal Drug Delivery Market Share by Application in 2022 & 2028
Figure 23. United States Transmucosal Drug Delivery Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Transmucosal Drug Delivery Market Share by Application (2017-2028)
Figure 25. North America Transmucosal Drug Delivery Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Transmucosal Drug Delivery Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Transmucosal Drug Delivery Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Transmucosal Drug Delivery Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Transmucosal Drug Delivery Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. UAE Transmucosal Drug Delivery Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. 3M Pharmaceuticals Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 54. Acrux Limited Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 55. ALZA Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 56. Antares Pharma, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 57. Apricus BioSciences, Inc Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 58. Aveva Drug Delivery Systems Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 59. Corium International, Inc Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 60. DURECT Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 61. Generex Biotechnology Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 62. Inovio Pharmaceuticals, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 63. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 64. MedPharm LTD Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 65. Mylan, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 66. Nemaura Pharma Ltd Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 67. Nitto Denko Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 68. Noven Pharmaceuticals, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 69. Pantec Biosolutions AG Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 70. Tapemark Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 71. tesa Labtec GmbH Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 72. TEVA Pharmaceutical Industries Ltd. Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 73. Zosano Pharma Revenue Growth Rate in Transmucosal Drug Delivery Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gold Nanoparticles Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121

Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......

Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109

Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......

Global Gold Nanoparticles Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......

Global Liposome Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123

According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......

Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......

Global Liposomes Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......

Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129

According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......

Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs